Skip to main content
. 2009 Jan 9;30(7):850–856. doi: 10.1093/eurheartj/ehn573

Table 1.

Study sample characteristics

Characteristic n = 1267
Age (years) 60 ± 9
Women (%) 53.8 (682)
Body mass index (kg/m2) 28.2 ± 5.1
Waist circumference (cm) 94.2 ± 13.7
Pericardial fat (cm3) 124 ± 50
Intrathoracic fat (cm3) 115 ± 63
Visceral abdominal fat (cm3) 2091 ± 1099
Systolic blood pressure (mmHg) 126 ± 18
Hypertensive treatment (%) 29.1 (369)
HDL cholesterol (mg/dL) 53.2 ± 16.0
Total cholesterol (mg/dL) 201 ± 36
Lipid-lowering treatment (%) 18.4 (233)
Diabetesa (%) 9.8 (124)

Smoking (%)
 Current 10.2 (129)
 Former 51.9 (657)
 Never 38.0 (481)

Alcohol useb (%) 16.3 (207)
Post-menopausal (%) 82.7 (564)
Hormone replacement therapy (%) 36.7 (250)

All CVD (%) 9.7 (123)
 CHD (%) 6.3 (80)
 Myocardial infarction (%) 3.1 (39)
 Stroke (%) 1.5 (19)
 CHF (%) 0.2 (3)
Intermittent claudication (%) 1.9 (24)

Data presented as mean ± standard deviation for continuous traits or per cent (n) for dichotomous traits. CVD, cardiovascular disease; CHD, coronary heart disease; HDL, high density lipoprotein; CVD, cardiovascular disease; CHF, congestive heart failure.

aDefined as fasting plasma glucose ≥126 mg/dL or treatment with either insulin or a hypoglycaemic agent.

bDefined as more than 14 drinks per week (men) or more than seven drinks per week (women).